A TSHRN1201 Sub-study-To Evaluate the Effects of add-on Ranolazine on Exercise Tolerance and Angina Frequency
Clinical trial NCT03401502 · COMPLETED
Trial details
- NCT number
- NCT03401502
- Sponsor
- TSH Biopharm Corporation Limited
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-07
- Primary completion
- 2019-03-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.